Intuitive Surgical (NASDAQ:ISRG) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says

Intuitive Surgical (NASDAQ:ISRG) had its price target increased by research analysts at Wells Fargo & Company from $630.00 to $687.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has an “overweight” rating on the medical equipment provider’s stock. Wells Fargo & Company‘s target price points to a potential upside of 18.48% from the stock’s current price.

ISRG has been the subject of several other reports. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Piper Sandler reaffirmed an “overweight” rating and set a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Leerink Partners increased their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Robert W. Baird increased their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Finally, Mizuho increased their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $566.83.

Intuitive Surgical Price Performance

Intuitive Surgical stock traded down $28.84 during midday trading on Friday, reaching $579.82. 1,433,056 shares of the company traded hands, compared to its average volume of 1,766,640. The firm has a market capitalization of $206.52 billion, a price-to-earnings ratio of 93.22, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The business has a 50 day moving average of $544.61 and a two-hundred day moving average of $502.64. Intuitive Surgical has a 12 month low of $364.17 and a 12 month high of $616.00.

Insider Activity at Intuitive Surgical

In related news, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the sale, the chief executive officer now owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. The trade was a 1.22 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 42,475 shares of company stock worth $22,070,807 in the last three months. Company insiders own 0.90% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

A number of large investors have recently modified their holdings of the business. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at about $26,000. Godsey & Gibb Inc. boosted its position in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new position in shares of Intuitive Surgical during the 3rd quarter valued at about $33,000. Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at about $36,000. Finally, Capital Performance Advisors LLP acquired a new position in shares of Intuitive Surgical during the 3rd quarter valued at about $38,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.